Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.016,83
0,72%
NASDAQ
19.996,86
-0,17%
Bitcoin
95.288,56
-4,04%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ HOOKIPA Pharma Inc (HOOK) HOOKIPA Pharma Inc (HOOK) Notizie

HOOKIPA Pharma Inc

HOOK
1,90
0,005 (0,26%)
Ultimo aggiornamento: 15:35:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202422:09EDGAR2Form 8-K - Current report
14/11/202422:07EDGAR2Form 8-K - Current report
30/8/202414:04EDGAR2Form 8-K - Current report
08/8/202423:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/8/202423:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:32EDGAR2Form 8-K - Current report
08/8/202422:30GLOBEHOOKIPA Pharma Reports Second Quarter 2024 Financial..
03/8/202400:38EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
26/7/202422:08EDGAR2Form 8-K - Current report
24/7/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/7/202414:30GLOBEHOOKIPA Pharma Announces Leadership Changes to Intensify..
10/7/202413:00EDGAR2Form 8-K - Current report
08/7/202413:01GLOBEHOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse..
01/7/202422:31GLOBEHOOKIPA Pharma Announces First Person Dosed in Phase 1b..
18/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202422:03EDGAR2Form 8-K - Current report
04/6/202422:15EDGAR2Form 8-K - Current report
04/6/202419:00GLOBEHOOKIPA Pharma Announces Updated Phase 2 Clinical Data at..
30/5/202422:30GLOBEHOOKIPA Pharma to Host Investor Call on HB-200 Data..
23/5/202423:05EDGAR2Form 8-K - Current report
23/5/202423:01GLOBEHOOKIPA Pharma Announces Positive Clinical Data to be..
09/5/202413:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:03EDGAR2Form 8-K - Current report
09/5/202413:01GLOBEHOOKIPA Pharma Reports First Quarter 2024 Financial..
25/4/202413:01GLOBEHOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for..
24/4/202413:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its..
16/4/202422:30GLOBEHOOKIPA Pharma Announces Grant of Inducement Award Under..
10/4/202413:01GLOBEHOOKIPA Pharma to Host Investor Call on HB-200 and Planned..
22/3/202412:01GLOBEHOOKIPA Pharma Reports Fourth Quarter and Full Year 2023..
06/3/202413:01GLOBEHOOKIPA Pharma to Participate in Leerink Partners Global..
31/1/202422:30EDGAR2Form 8-K - Current report
29/1/202414:12EDGAR2Form 8-K - Current report
29/1/202414:01GLOBEHOOKIPA Pharma Provides Update on Business Priorities and..
16/1/202413:01GLOBEHOOKIPA Pharma Appoints Mark Winderlich as Chief Development..
05/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
Apertura: 1,90 Min: 1,90 Max: 1,90
Chiusura: 1,895

La tua Cronologia

NASDAQ
HOOK
HOOKIPA Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network